You have 9 free searches left this month | for more free features.

NMRA-140

Showing 1 - 25 of 606

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDD Trial in United States (BTRX-335140, Placebo)

Active, not recruiting
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +37 more
Mar 11, 2022

MDD Trial (NMRA-335140)

Not yet recruiting
  • Major Depressive Disorder
  • (no location specified)
Sep 1, 2023

MDD Trial (NMRA-335140, Placebo)

Not yet recruiting
  • Major Depressive Disorder
  • (no location specified)
Sep 21, 2023

MDD Trial (NMRA-335140, Placebo)

Not yet recruiting
  • Major Depressive Disorder
  • (no location specified)
Sep 21, 2023

MDD Trial (NMRA 335140, Placebo)

Not yet recruiting
  • Major Depressive Disorder
  • NMRA 335140
  • Placebo
  • (no location specified)
Sep 1, 2023

Osteoarthritis Wrist Trial (Self-managed exercise therapy program, Partial wrist denervation)

Not yet recruiting
  • Osteoarthritis Wrist
  • Self-managed exercise therapy program
  • Partial wrist denervation
  • (no location specified)
Oct 24, 2023

Medullary Thyroid Cancer Trial in Worldwide (Cabozantinib (XL184) 140 mg, Cabozantinib (XL184) 60 mg, Placebo tablet)

Active, not recruiting
  • Medullary Thyroid Cancer
  • Cabozantinib (XL184) 140 mg
  • +3 more
  • St. Leonards, New South Wales, Australia
  • +49 more
Jan 23, 2023

CCR5, Microsatellite Stable, Metastatic Trial (700mg leronlimab weekly dose, 80mg Regorafenib at week 1, 120mg Regorafenib at

Withdrawn
  • CCR5
  • +3 more
  • 700mg leronlimab weekly dose
  • +3 more
  • (no location specified)
Feb 15, 2023

Blood Pressure, Perioperative Hypotension Trial in Hamburg (Continuous norepinephrine infusion via an infusion pump, Manual

Not yet recruiting
  • Blood Pressure
  • Perioperative Hypotension
  • Continuous norepinephrine infusion via an infusion pump
  • Manual bolus norepinephrine administration
  • Hamburg, Germany
    Universitätsklinikum Hamburg-Eppendorf
Aug 10, 2023

Systemic Lupus Erythematosus Trial (GLPG3667, Placebo)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • (no location specified)
May 4, 2023

Preeclampsia Trial (Antihypertensive treatment)

Not yet recruiting
  • Preeclampsia
  • Antihypertensive treatment
  • (no location specified)
Jan 9, 2023

Time Spent In Target Glucose Range in T2D Diabetes in Pregnancy

Recruiting
  • Diabete Type 2
  • Pregnancy in Diabetic
  • Dexcom Continuous Glucose Monitoring
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Nov 21, 2023

The CARDIO-TTRansform Scintigraphy Sub-study

Active, not recruiting
  • Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
  • Scintigraphy scan
  • New York, New York
  • +4 more
Oct 4, 2023

Essential Hypertension, Primary Hypertension Trial (Amicomed®, Digital Placebo, Usual Care)

Not yet recruiting
  • Essential Hypertension
  • Primary Hypertension
  • Amicomed®
  • +2 more
  • (no location specified)
Oct 19, 2023

Coronavirus Disease 2019 Trial in United States (Placebos, Leronlimab (700mg))

Completed
  • Coronavirus Disease 2019
  • Placebo
  • Leronlimab (700mg)
  • Los Angeles, California
  • +11 more
Dec 8, 2022

Hyperlipidemia, Mixed Dyslipidemia Trial in Denver (Evolocumab)

Completed
  • Hyperlipidemia
  • Mixed Dyslipidemia
  • Evolocumab
  • Denver, Colorado
    Research Site
Nov 3, 2022

HIV-1-infection Trial in San Francisco (PRO 140 350, PRO 140 525, PRO 140 700)

Active, not recruiting
  • HIV-1-infection
  • PRO 140 350
  • +2 more
  • San Francisco, California
    Quest Clinical Research
Mar 4, 2022

Hypertension Trial in United States (Anti-hypertensive therapy, No anti-hypertensive therapy (unless BP is severe))

Completed
  • Hypertension
  • Anti-hypertensive therapy
  • No anti-hypertensive therapy (unless BP is severe)
  • Birmingham, Alabama
  • +71 more
Dec 16, 2022

End Stage Renal Disease on Dialysis Trial in San Francisco, Seattle (Dry weight target adjustment, Anti-hypertensive

Recruiting
  • End Stage Renal Disease on Dialysis
  • Dry weight target adjustment
  • Anti-hypertensive medications
  • San Francisco, California
  • +1 more
Jun 2, 2022

Menopausal Hot Flashes Trial in Oakland, San Francisco (transdermal nitroglycerin, Placebo)

Completed
  • Menopausal Hot Flashes
  • transdermal nitroglycerin
  • Placebo
  • Oakland, California
  • +1 more
Dec 14, 2022

Diabetes, Type 2 Trial in United States (Blinded CGM, real-time CGM)

Recruiting
  • Diabetes Mellitus, Type 2
  • Blinded CGM
  • real-time CGM
  • Aurora, Colorado
  • +5 more
Nov 23, 2022

Solid Tumor, Adult Trial in San Francisco (Leronlimab)

Active, not recruiting
  • Solid Tumor, Adult
  • San Francisco, California
    Quest Clinical Research
Jun 30, 2022

Lower Eyelid Steatoblepharon Trial in Newport Beach (POLAT-001, Placebo)

Recruiting
  • Lower Eyelid Steatoblepharon
  • Newport Beach, California
    Medical Associates, Inc.
Jun 29, 2023

Ultrasound for Socket Healing Evaluation

Not yet recruiting
  • Healing Wound
  • +4 more
    • (no location specified)
    Aug 23, 2023

    HIV Trial in United States (PRO 140 (350 mg), PRO 140 (525 mg), PRO 140 (700 mg))

    Active, not recruiting
    • HIV
    • PRO 140 (350 mg)
    • +2 more
    • La Mesa, California
    • +11 more
    Jan 13, 2022